Skip to main content

Table 2 Comparison of pathological manifestations between the patients in remission and patients with relapse

From: Clinical and pathological predictors of relapse in IgG4-related disease

 

Patients in remission (n = 47)

Patients with relapse (n = 21)

p

Number of IgG4+ plasma cells/HPF

50 (25–120)

70 (40–290)

0.013*

Ratio of IgG4+ cell/IgG+ cell (%)

40.0 (30.0–56.0)

40.7 (40.0–59.5)

0.644*

Severe IgG4+ plasma cell infiltration (≥60/HPF in visceral organs or ≥200/HPF in head and neck organs)

21 (44.7%)

18 (85.7%)

0.002**

Fibrosis

39 (83.0)

18 (85.7)

0.777**

Storiform fibrosis

7 (14.9)

2 (9.5)

0.546**

Obliterative phlebitis

16 (34.0)

7 (33.3)

0.954**

Eosinophilic infiltration

5 (10.6)

1 (4.8)

0.430**

Lymphoid follicle formation

18 (38.3)

3 (14.3)

0.048**

Germinal center formation

5 (10.6)

1 (4.8)

0.430**

  1. Data are n (%) or median (interquartile range). Statistically significant p values are in bold font
  2. HPF high-power field
  3. *Mann–Whitney U test, **chi-square test